Ortho Molecular Products Revenue and Competitors
Estimated Revenue & Valuation
- Ortho Molecular Products's estimated annual revenue is currently $109M per year.
- Ortho Molecular Products's estimated revenue per employee is $337,500
Employee Data
- Ortho Molecular Products has 323 Employees.
- Ortho Molecular Products grew their employee count by 9% last year.
Ortho Molecular Products Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $107.3M | 313 | -24% | $25.5M | N/A |
#2 | $1369.5M | 3623 | N/A | N/A | N/A |
#3 | $8.9M | 41 | -11% | N/A | N/A |
#4 | $10.8M | 50 | N/A | N/A | N/A |
#5 | $49.6M | 167 | N/A | N/A | N/A |
#6 | $24.6M | 91 | -3% | N/A | N/A |
#7 | $9.5M | 44 | 26% | N/A | N/A |
#8 | $5.1M | 27 | N/A | N/A | N/A |
#9 | $9.9M | 46 | 18% | N/A | N/A |
#10 | $6.7M | 31 | 7% | N/A | N/A |
What Is Ortho Molecular Products?
For more than 30 years, Ortho Molecular Products has partnered exclusively with health care providers to deliver nutritional solutions of the highest efficacy. The most trusted voices in health care put their trust in our products to help patients get better, faster. Our commitment to science, careful raw ingredient selection, and strict quality standards goes into every supplement we formulate.
keywords:N/AN/A
Total Funding
323
Number of Employees
$109M
Revenue (est)
9%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Ortho Molecular Products News
Two P fertilizer formulas based on orthophosphates (Ortho-P) and ... each treatment as the sum of the product of root and shoot dry biomass...
The company's proposed acquisition of Ortho Clinical Diagnostics (OCDX) ... The reason is that the company's molecular diagnostic products...
Amides are ubiquitous in biologically active natural products and ... Additionally, use of interpretable molecular descriptors allows the...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $73.1M | 334 | 14% | N/A |
#2 | $148.5M | 360 | 22% | N/A |
#3 | $173.3M | 420 | 11% | N/A |
#4 | $146.5M | 434 | 12% | N/A |
#5 | $35M | 452 | -5% | N/A |